Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana

被引:11
|
作者
Kobia-Acquah, Emmanuel [1 ]
Gyekye, Gloria Atta-Penkra [1 ]
Antwi-Adjei, Ellen K. [1 ]
Koomson, Nana Y. [1 ]
Cobbina, Francis [2 ]
Donkor, Richard [3 ]
Akowuah, Prince K. [1 ,4 ]
机构
[1] Kwame Nkrumah Univ Sci & Technol, Dept Optometry & Visual Sci, Private Mail Bag,Univ Post Off, Kumasi, Ashanti Region, Ghana
[2] Jachie Eye Hosp, Jachie, Ashanti Region, Ghana
[3] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada
[4] Univ Houston, Coll Optometry, Houston, TX USA
关键词
ocular surface disease; dry eye disease; glaucoma; Ghana; Ocular Surface Disease Index; QUALITY-OF-LIFE; OPEN-ANGLE GLAUCOMA; EYE MEDICINE USE; DRY EYE; RISK-FACTORS; PREVALENCE; HYPERTENSION; PERSPECTIVES; SYMPTOMS;
D O I
10.1097/IJG.0000000000001713
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis: Dry eye disease (DED) observed in this study is associated with ocular surface abnormalities as shown by specific dry eye tests. Changes in tear quality may be responsible for dry eye symptoms among the participants. Purpose: This study sought to evaluate DED in glaucoma patients in Ghana. Materials and Methods: This was a hospital-based descriptive cross-sectional study involving glaucoma patients on topical glaucoma treatment for at least 6 months. The medical records of participants were thoroughly reviewed for information on demographics, ocular history, medical history, number of topical antiglaucoma medications used within the last 6 months, and any other ophthalmic medications used by the participants. An Ocular Surface Disease Index (OSDI) questionnaire was administered to each participant, after which Schirmer test and tear break-up time (TBUT) were performed on each participant in a controlled environment. Results: A total of 100 individuals participated in the study. The mean +/- SD age of participants was 60.44 +/- 14.05 years. The majority (60.0%) of the participants were females and 55.0% of participants used 2 or more topical antiglaucoma medication. Of the participants, 81.0% reported subjective dry eye symptoms. Schirmer test and TBUT showed that 55.0% and 87.0% of the participants had decreased tear production and abnormal tear quality, respectively. Multiple logistic regression showed a significant association between age and abnormal OSDI (P=0.037), Schirmer test (P=0.003), and TBUT (P=0.042); the number of topical glaucoma medications and OSDI (P=0.016) and Schirmer test (P=0.009). The prevalence of DED was 23.0%. Increasing age was associated with an similar to 7 times higher odds of having DED (P=0.0019), using >2 glaucoma medications with similar to 4.5 times higher odds of having DED (P=0.001), 5 or more years of glaucoma medication use with similar to 4 times higher odds of DED (P=0.009), and both benzalkonium chloride and sodium chlorite as preservative was associated with similar to 3.5 times higher odds of DED (P=0.047). Conclusion: DED is prevalent among glaucoma patients in Ghana and is associated with age, duration of glaucoma medication, type of preservatives, and number of topical glaucoma medications.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [1] High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
    Ruangvaravate, Ngamkae
    Prabhasawat, Pinnita
    Vachirasakchai, Virunya
    Tantimala, Ratchadaporn
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (05) : 387 - 394
  • [2] Ocular Surface Disease in Patients with Ocular Hypertension and Glaucoma
    Stewart, William C.
    Stewart, Jeanette A.
    Nelson, Lindsay A.
    CURRENT EYE RESEARCH, 2011, 36 (05) : 391 - 398
  • [3] Evaluation of Ocular Surface Disease in Patients with Glaucoma
    Mathews, Priya M.
    Ramulu, Pradeep Y.
    Friedman, David S.
    Utine, Canan A.
    Akpek, Esen K.
    OPHTHALMOLOGY, 2013, 120 (11) : 2241 - 2248
  • [4] Ocular Surface Disease in Glaucoma Patients
    Scelfo, Christina
    ElSheikh, Reem H.
    Shamim, Muhammad M.
    Abbasian, Javaneh
    Ghaffarieh, Alireza
    Elhusseiny, Abdelrahman M.
    CURRENT EYE RESEARCH, 2023, 48 (03) : 219 - 230
  • [5] Glaucoma and Ocular Surface Disease: More than Meets the Eye
    Li, Gavin
    Akpek, Esen Karamursel
    Ahmad, Sumayya
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 3641 - 3649
  • [6] The influence of ocular surface diseases in the management of glaucoma
    Van Went, C.
    Brasnu, E.
    Hamard, P.
    Baudouin, C.
    Labbe, A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2011, 34 (04): : 230 - 237
  • [7] Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
    Mylla Boso, Ana Luiza
    Gasperi, Erica
    Fernandes, Leticia
    Costa, Vital Paulino
    Alves, Monica
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 103 - 111
  • [8] Ocular surface disease in glaucoma patients: Expert opinion and management algorithm in Algeria
    Lazreg, Sihem
    Garout, Rachid
    Boulanab, Fouzia
    Aberkane, Djalil
    Djabour, Mustapha
    Boudedja, Hakim
    Acheli, Asma
    Derdour, Amine
    El Abidine, Nairouz Zine
    Ghemri, Nadia
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (02): : 152 - 162
  • [9] Challenges in the clinical measurement of ocular surface disease in glaucoma patients
    Pflugfelder, Stephen C.
    Baudouin, Christophe
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 1575 - 1583
  • [10] Ocular Surface Disease and Glaucoma Medications: A Clinical Approach
    Zhang, Xuemin
    Vadoothker, Saujanya
    Munir, Wuqaas M.
    Saeedi, Osamah
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2019, 45 (01): : 11 - 18